Clinical trial

Maintenance Neoral Monotherapy Compared to Bitherapy in Renal Transplantation

NCT00461825 · Poitiers University Hospital, Other · Completed

Key facts

NCT number NCT00461825
Title Maintenance Neoral Monotherapy Compared to Bitherapy in Renal Transplantation
Official title Efficacy and Safety of Maintenance Neoral Compared to Bitherapy Neoral-Imurel or Neoral-CellCept in Renal Transplantation
Lead sponsor Poitiers University Hospital, Other
Status Completed
Phase Phase 3
Study type Interventional
Conditions Kidney Transplantation
Intervention type Drug
Interventions Cyclosporin A: C0: 75-125ng/ml-dose adapted in the 3 groups, Group A: CsA + Azathioprine(1 to 2 mg/kg/day), Group B: CsA + CellCept(500 mg x 2/day), Group C: CsAm
Enrollment 207
Start date Jul 1, 1998
Completion Feb 1, 2007
First posted Apr 18, 2007
Last update posted Apr 18, 2007
Countries France

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies